NCT07359053 2026-01-22
MAGNATE-S
Shanghai 6th People's Hospital
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07205185 2025-10-03
A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.
Fudan University
Phase 2 Not yet recruiting
NCT04165330 2025-02-24
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Sarcoma Oncology Research Center, LLC
Phase 1/2 Active not recruiting
NCT06506838 2024-08-12
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Guangdong Provincial People's Hospital
Phase 4 Recruiting
NCT03890068 2023-08-01
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04172805 2023-04-12
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05602415 2022-11-02
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Ruijin Hospital
Phase 2 Unknown
NCT04765228 2021-02-21
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT03946943 2019-07-10
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
The First Hospital of Jilin University
Phase 2 Unknown
NCT03792542 2019-01-03
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown